Annual EBITDA:
$23.07M+$99.43M(+130.21%)Summary
- As of today, EXAS annual EBITDA is $23.07 million, with the most recent change of +$99.43 million (+130.21%) on December 31, 2024.
- During the last 3 years, EXAS annual EBITDA has risen by +$546.11 million (+104.41%).
- EXAS annual EBITDA is now at all-time high.
Performance
EXAS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$58.05M+$102.03M(+231.97%)Summary
- As of today, EXAS quarterly EBITDA is $58.05 million, with the most recent change of +$102.03 million (+231.97%) on June 30, 2025.
- Over the past year, EXAS quarterly EBITDA has increased by +$26.95 million (+86.68%).
- EXAS quarterly EBITDA is now at all-time high.
Performance
EXAS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$51.09M+$26.95M(+111.66%)Summary
- As of today, EXAS TTM EBITDA is $51.09 million, with the most recent change of +$26.95 million (+111.66%) on June 30, 2025.
- Over the past year, EXAS TTM EBITDA has increased by +$111.67 million (+184.34%).
- EXAS TTM EBITDA is now at all-time high.
Performance
EXAS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EXAS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +130.2% | +86.7% | +184.3% |
3Y3 Years | +104.4% | +187.8% | +110.8% |
5Y5 Years | +120.0% | +225.9% | +211.6% |
EXAS EBITDA Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +104.4% | at high | +184.1% | at high | +111.2% |
5Y | 5-Year | at high | +104.4% | at high | +124.1% | at high | +109.0% |
All-Time | All-Time | at high | +104.4% | at high | +124.1% | at high | +109.0% |
EXAS EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $58.05M(+232.0%) | $51.09M(+111.7%) |
Mar 2025 | - | -$43.98M(-486.7%) | $24.14M(+66.6%) |
Dec 2024 | $23.07M(+130.2%) | $11.37M(-55.7%) | $14.48M(+166.0%) |
Sep 2024 | - | $25.66M(-17.5%) | -$21.95M(+63.8%) |
Jun 2024 | - | $31.09M(+158.0%) | -$60.58M(+45.2%) |
Mar 2024 | - | -$53.64M(-114.0%) | -$110.64M(-42.8%) |
Dec 2023 | -$76.36M(+80.7%) | -$25.06M(-93.2%) | -$77.47M(+31.6%) |
Sep 2023 | - | -$12.97M(+31.6%) | -$113.19M(+33.1%) |
Jun 2023 | - | -$18.97M(+7.4%) | -$169.25M(+21.8%) |
Mar 2023 | - | -$20.47M(+66.3%) | -$216.40M(+37.2%) |
Dec 2022 | -$394.72M(+24.5%) | -$60.78M(+11.9%) | -$344.58M(+24.2%) |
Sep 2022 | - | -$69.03M(-4.4%) | -$454.58M(+3.9%) |
Jun 2022 | - | -$66.12M(+55.5%) | -$472.83M(+1.0%) |
Mar 2022 | - | -$148.66M(+13.0%) | -$477.45M(+16.2%) |
Dec 2021 | -$523.04M(-2511.8%) | -$170.77M(-95.7%) | -$569.60M(-59.7%) |
Sep 2021 | - | -$87.28M(-23.4%) | -$356.74M(-65.3%) |
Jun 2021 | - | -$70.74M(+70.6%) | -$215.82M(-12.9%) |
Mar 2021 | - | -$240.80M(-672.2%) | -$191.19M(-2023.2%) |
Dec 2020 | $21.69M(+118.8%) | $42.09M(-21.5%) | $9.94M(+121.7%) |
Sep 2020 | - | $53.64M(+216.3%) | -$45.77M(+63.4%) |
Jun 2020 | - | -$46.11M(-16.2%) | -$125.06M(-20.2%) |
Mar 2020 | - | -$39.67M(-191.1%) | -$104.08M(+16.4%) |
Dec 2019 | -$115.31M(+15.5%) | -$13.63M(+46.9%) | -$124.47M(+18.8%) |
Sep 2019 | - | -$25.65M(-2.0%) | -$153.27M(+5.6%) |
Jun 2019 | - | -$25.14M(+58.1%) | -$162.39M(+1.5%) |
Mar 2019 | - | -$60.06M(-41.6%) | -$164.81M(-20.8%) |
Dec 2018 | -$136.39M(-32.7%) | -$42.43M(-22.0%) | -$136.39M(-21.1%) |
Sep 2018 | - | -$34.77M(-26.1%) | -$112.64M(-10.2%) |
Jun 2018 | - | -$27.56M(+12.9%) | -$102.22M(+0.1%) |
Mar 2018 | - | -$31.64M(-69.3%) | -$102.33M(+0.5%) |
Dec 2017 | -$102.75M(+34.8%) | -$18.68M(+23.2%) | -$102.89M(+13.4%) |
Sep 2017 | - | -$24.34M(+12.0%) | -$118.84M(+8.4%) |
Jun 2017 | - | -$27.67M(+14.1%) | -$129.74M(+10.1%) |
Mar 2017 | - | -$32.19M(+7.1%) | -$144.34M(+8.4%) |
Dec 2016 | -$157.51M(-4.1%) | -$34.64M(+1.7%) | -$157.51M(+2.2%) |
Sep 2016 | - | -$35.24M(+16.6%) | -$161.10M(+3.6%) |
Jun 2016 | - | -$42.27M(+6.8%) | -$167.20M(-2.9%) |
Mar 2016 | - | -$45.36M(-18.6%) | -$162.50M(-7.2%) |
Dec 2015 | -$151.32M(-56.3%) | -$38.23M(+7.5%) | -$151.57M(-4.9%) |
Sep 2015 | - | -$41.34M(-10.0%) | -$144.47M(-7.5%) |
Jun 2015 | - | -$37.58M(-9.2%) | -$134.43M(-16.2%) |
Mar 2015 | - | -$34.42M(-10.6%) | -$115.73M(-19.5%) |
Dec 2014 | -$96.83M(-113.5%) | -$31.14M(+0.5%) | -$96.83M(-24.9%) |
Sep 2014 | - | -$31.29M(-65.7%) | -$77.52M(-35.6%) |
Jun 2014 | - | -$18.88M(-21.6%) | -$57.15M(-13.6%) |
Mar 2014 | - | -$15.52M(-31.3%) | -$50.28M(-10.9%) |
Dec 2013 | -$45.34M(+12.2%) | -$11.82M(-8.3%) | -$45.34M(+4.0%) |
Sep 2013 | - | -$10.92M(+9.2%) | -$47.24M(+3.8%) |
Jun 2013 | - | -$12.02M(-13.6%) | -$49.08M(+5.1%) |
Mar 2013 | - | -$10.58M(+22.9%) | -$51.74M(-0.2%) |
Dec 2012 | -$51.66M | -$13.72M(-7.6%) | -$51.66M(-22.4%) |
Sep 2012 | - | -$12.76M(+13.1%) | -$42.20M(-13.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | -$14.68M(-39.8%) | -$37.16M(-27.9%) |
Mar 2012 | - | -$10.50M(-146.2%) | -$29.05M(-26.9%) |
Dec 2011 | -$28.42M(-145.1%) | -$4.26M(+44.8%) | -$22.89M(-2.3%) |
Sep 2011 | - | -$7.73M(-17.7%) | -$22.39M(-24.4%) |
Jun 2011 | - | -$6.56M(-51.4%) | -$17.99M(-29.9%) |
Mar 2011 | - | -$4.33M(-15.3%) | -$13.86M(-19.5%) |
Dec 2010 | -$11.60M(-40.1%) | -$3.76M(-12.8%) | -$11.60M(-20.6%) |
Sep 2010 | - | -$3.33M(-37.4%) | -$9.62M(-31.0%) |
Jun 2010 | - | -$2.43M(-17.0%) | -$7.34M(+0.0%) |
Mar 2010 | - | -$2.08M(-16.6%) | -$7.34M(+18.7%) |
Dec 2009 | -$8.28M(+5.4%) | -$1.78M(-68.2%) | -$9.04M(+1.5%) |
Sep 2009 | - | -$1.06M(+56.4%) | -$9.17M(+13.2%) |
Jun 2009 | - | -$2.43M(+35.6%) | -$10.56M(-6.0%) |
Mar 2009 | - | -$3.77M(-96.8%) | -$9.96M(-13.9%) |
Dec 2008 | -$8.74M(+20.9%) | -$1.92M(+21.8%) | -$8.74M(+17.4%) |
Sep 2008 | - | -$2.45M(-33.7%) | -$10.58M(+8.6%) |
Jun 2008 | - | -$1.83M(+28.2%) | -$11.58M(+1.0%) |
Mar 2008 | - | -$2.55M(+32.0%) | -$11.69M(-5.7%) |
Dec 2007 | -$11.06M(+11.2%) | -$3.75M(-9.1%) | -$11.06M(-21.0%) |
Sep 2007 | - | -$3.44M(-77.1%) | -$9.14M(-5.2%) |
Jun 2007 | - | -$1.94M(-1.3%) | -$8.69M(+12.3%) |
Mar 2007 | - | -$1.92M(-4.5%) | -$9.90M(+18.3%) |
Dec 2006 | -$12.45M(+9.1%) | -$1.84M(+38.5%) | -$12.13M(+6.1%) |
Sep 2006 | - | -$2.99M(+5.5%) | -$12.91M(+1.2%) |
Jun 2006 | - | -$3.16M(+23.7%) | -$13.06M(+5.1%) |
Mar 2006 | - | -$4.14M(-58.1%) | -$13.76M(-2.1%) |
Dec 2005 | -$13.70M(+21.6%) | -$2.62M(+16.6%) | -$13.48M(+11.3%) |
Sep 2005 | - | -$3.14M(+18.6%) | -$15.19M(+6.3%) |
Jun 2005 | - | -$3.86M(-0.0%) | -$16.20M(+1.1%) |
Mar 2005 | - | -$3.86M(+10.9%) | -$16.38M(+6.2%) |
Dec 2004 | -$17.47M(+32.9%) | -$4.33M(-4.0%) | -$17.47M(+4.8%) |
Sep 2004 | - | -$4.16M(-3.0%) | -$18.34M(+9.6%) |
Jun 2004 | - | -$4.04M(+18.3%) | -$20.29M(+13.7%) |
Mar 2004 | - | -$4.94M(+5.0%) | -$23.50M(+9.7%) |
Dec 2003 | -$26.03M(+9.3%) | -$5.20M(+14.9%) | -$26.03M(+4.9%) |
Sep 2003 | - | -$6.11M(+15.7%) | -$27.38M(+3.4%) |
Jun 2003 | - | -$7.25M(+2.9%) | -$28.34M(+1.4%) |
Mar 2003 | - | -$7.46M(-13.9%) | -$28.74M(-0.2%) |
Dec 2002 | -$28.69M(-14.4%) | -$6.55M(+7.4%) | -$28.69M(-0.9%) |
Sep 2002 | - | -$7.07M(+7.5%) | -$28.44M(-3.8%) |
Jun 2002 | - | -$7.65M(-3.2%) | -$27.39M(-5.2%) |
Mar 2002 | - | -$7.41M(-17.6%) | -$26.04M(-5.8%) |
Dec 2001 | -$25.08M(-94.0%) | -$6.30M(-4.5%) | -$24.62M(-3.6%) |
Sep 2001 | - | -$6.03M(+4.3%) | -$23.76M(-34.0%) |
Jun 2001 | - | -$6.30M(-5.2%) | -$17.73M(-55.1%) |
Mar 2001 | - | -$5.99M(-10.0%) | -$11.43M(-114.0%) |
Dec 2000 | -$12.93M(-167.1%) | - | - |
Dec 2000 | - | -$5.44M(-5506.0%) | -$5.34M(-5406.0%) |
Mar 2000 | - | $100.70K | $100.70K |
Dec 1999 | -$4.84M(-28.1%) | - | - |
Dec 1998 | -$3.78M(-96.5%) | - | - |
Dec 1997 | -$1.92M | - | - |
FAQ
- What is Exact Sciences Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Exact Sciences Corporation?
- What is Exact Sciences Corporation annual EBITDA year-on-year change?
- What is Exact Sciences Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Exact Sciences Corporation?
- What is Exact Sciences Corporation quarterly EBITDA year-on-year change?
- What is Exact Sciences Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Exact Sciences Corporation?
- What is Exact Sciences Corporation TTM EBITDA year-on-year change?
What is Exact Sciences Corporation annual EBITDA?
The current annual EBITDA of EXAS is $23.07M
What is the all-time high annual EBITDA for Exact Sciences Corporation?
Exact Sciences Corporation all-time high annual EBITDA is $23.07M
What is Exact Sciences Corporation annual EBITDA year-on-year change?
Over the past year, EXAS annual EBITDA has changed by +$99.43M (+130.21%)
What is Exact Sciences Corporation quarterly EBITDA?
The current quarterly EBITDA of EXAS is $58.05M
What is the all-time high quarterly EBITDA for Exact Sciences Corporation?
Exact Sciences Corporation all-time high quarterly EBITDA is $58.05M
What is Exact Sciences Corporation quarterly EBITDA year-on-year change?
Over the past year, EXAS quarterly EBITDA has changed by +$26.95M (+86.68%)
What is Exact Sciences Corporation TTM EBITDA?
The current TTM EBITDA of EXAS is $51.09M
What is the all-time high TTM EBITDA for Exact Sciences Corporation?
Exact Sciences Corporation all-time high TTM EBITDA is $51.09M
What is Exact Sciences Corporation TTM EBITDA year-on-year change?
Over the past year, EXAS TTM EBITDA has changed by +$111.67M (+184.34%)